These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 13764412)
1. Tranylcypromine (Parnate) in the ambulatory treatment of depressed patients. LURIE ML; SALZER HM Am J Psychiatry; 1961 Aug; 118():152-5. PubMed ID: 13764412 [No Abstract] [Full Text] [Related]
2. Tranylcypromine in depression: a clinical report. AGIN HV Am J Psychiatry; 1960 Aug; 117():150-1. PubMed ID: 13792016 [No Abstract] [Full Text] [Related]
3. The use of Parnate in the treatment of depression. MILLER MH Am J Psychiatry; 1961 Nov; 118():454-5. PubMed ID: 14474076 [No Abstract] [Full Text] [Related]
4. Tranylcypromine (parnate) a new monoamine oxidase inhibitor. LEMERE F Am J Psychiatry; 1960 Sep; 117():249. PubMed ID: 14415582 [No Abstract] [Full Text] [Related]
5. A clinical trial of an antidepressant, tranylcy-promine ("Parnate"). KINGSTON WR Med J Aust; 1962 Jun; 49(1)():1011-2. PubMed ID: 14456153 [No Abstract] [Full Text] [Related]
6. Combined use of tranylcypromine and trifluoperazine in ambulatory treatment of patients with agitated depressions: Preliminary evaluation. LESSE S N Y State J Med; 1961 Jun; 61():1898-903. PubMed ID: 13761180 [No Abstract] [Full Text] [Related]
7. Tranylcypromine in the office treatment of depression. PELZMAN O Psychiatr Q; 1961 Apr; 35():261-7. PubMed ID: 13734049 [No Abstract] [Full Text] [Related]
8. Trifluoperazine and Tranylcypromine in chronic refractory schizophrenics. KRUSE W Am J Psychiatry; 1960 Dec; 117():548-9. PubMed ID: 13754637 [No Abstract] [Full Text] [Related]
9. Some pharmacological observations on tranylcypromine (SKF trans-385), a potent inhibitor of monoamine oxidase. TEDESCHI RE; TEDESCHI DH; AMES PL; COOK L; MATTIS PA; FELLOWS EJ Proc Soc Exp Biol Med; 1959 Nov; 102():380-1. PubMed ID: 13837261 [No Abstract] [Full Text] [Related]
10. The effect of tranylcypromine-trifluoperazine in the treatment of depressive states. BRAM G Can Psychiatr Assoc J; 1962; 7(Suppl)():84-6. PubMed ID: 13872435 [No Abstract] [Full Text] [Related]
11. Intracellular distribution of norepinephrine in rat brain. I. Effect of reserpine and the monoamine oxidase inhibitors, trans-2-phenylcyclopropylamine and 1-isonicotinyl-2-isopropyl hydrazine. GREEN H; SAWYER JL J Pharmacol Exp Ther; 1960 Jul; 129():243-9. PubMed ID: 13851489 [No Abstract] [Full Text] [Related]
12. The use of tranylcypromine and trifluoperazine in the management of coexisting depression and anxiety. GODDARD ES Can Psychiatr Assoc J; 1962; 7(Suppl)():87-90. PubMed ID: 13899397 [No Abstract] [Full Text] [Related]
13. Severe hypertension with parnate. SONGCO MF Am J Psychiatry; 1961 Oct; 118():360. PubMed ID: 13915189 [No Abstract] [Full Text] [Related]
14. The use of stelazine and parnate in chronic, withdrawn patients. VOGT AH Am J Psychiatry; 1961 Sep; 118():256-7. PubMed ID: 13781857 [No Abstract] [Full Text] [Related]
15. An evaluation of tranylcypromine ("Parnate") in the treatment of depression. BARTHOLOMEW AA Med J Aust; 1962 May; 49(1)():655-62. PubMed ID: 13865433 [No Abstract] [Full Text] [Related]
16. Combined tranylcypromine-trifluoperazine therapy in the treatment of patients with agitated depressions. LESSE S Am J Psychiatry; 1961 May; 117():1038-9. PubMed ID: 13761179 [No Abstract] [Full Text] [Related]
17. The relative merits of tranylcypromine alone and tranylcypromine in combination with trifluoperazine in the treatment of patients with severe agitated depressions. LESSE S Am J Psychiatry; 1962 Apr; 118():934-5. PubMed ID: 14464348 [No Abstract] [Full Text] [Related]
18. Further studies with tranylcypromine (monamine oxidase inhibitor) and its interaction with reserpine in rat brain. GREEN H; ERICKSON RW Arch Int Pharmacodyn Ther; 1962 Feb; 135():407-25. PubMed ID: 13901404 [No Abstract] [Full Text] [Related]